Post-acute COVID-19 associated with evidence of bystander t-cell activation and a recurring antibiotic-resistant bacterial pneumonia

  • Michaela Gregorova
  • , Daniel Morse
  • , Tarcisio Brignoli
  • , Joseph Steventon
  • , Fergus Hamilton
  • , Mahableshwar Albur
  • , David Arnold
  • , Matthew Thomas
  • , Alice Halliday
  • , Holly Baum
  • , Christopher Rice
  • , Matthew B. Avison
  • , Andrew D. Davidson
  • , Marianna Santopaolo
  • , Elizabeth Oliver
  • , Anu Goenka
  • , Adam Finn
  • , Linda Wooldridge
  • , Borko Amulic
  • , Rosemary J. Boyton
  • Daniel M. Altmann, David K. Butler, Claire McMurray, Joanna Stockton, Sam Nicholls, Charles Cooper, Nicholas Loman, Michael J. Cox, Laura Rivino, Ruth C. Massey

Research output: Contribution to journalArticlepeer-review

Abstract

Here, we describe the case of a COVID-19 patient who developed recurring ventilator- associated pneumonia caused by Pseudomonas aeruginosa that acquired increasing levels of antimicrobial resistance (AMR) in response to treatment. Metagenomic analysis revealed the AMR genotype, while immunological analysis revealed massive and escalating levels of T-cell activation. These were both SARS-CoV-2 and P. aeruginosa specific, and bystander activated, which may have contributed to this patient’s persistent symptoms and radiological changes.

Original languageEnglish
Article numbere63430
Pages (from-to)1-13
Number of pages13
JournaleLife
Volume9
DOIs
Publication statusPublished - Dec 2020
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Post-acute COVID-19 associated with evidence of bystander t-cell activation and a recurring antibiotic-resistant bacterial pneumonia'. Together they form a unique fingerprint.

Cite this